Global Breast Biopsy Market: Overview
A breast biopsy is a procedure used for the screening and diagnosis of breast cancer. This is not only limited to cancer but also other ailments of the breast such as a lump in the breast and others. In this procedure, a sample of the breast tissue is removed and tested in the laboratory to determine the presence of cancerous cells. These test results are evaluated and further course of treatment is determined. There are different types of breast biopsy procedures performed. These tests are helpful in detection of cancer in the early stages itself. Owing to the increasing awareness among women and availability of better medical facilities, demand in the breast biopsy market is growing gradually.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Global Breast Biopsy Market: Segmentation
The global breast biopsy market can be segmented into its type, guidance, product and geography. On the basis of type, the global market is divided into open surgical breast biopsy and needle breast biopsy. The needle breast biopsy is subdivided further into core-needle biopsy, fine-needle aspiration, biopsy and vacuum-assisted biopsy and the open surgical breast biopsy can be further subdivided into excisional breast biopsy and incisional breast biopsy. Based on guidance, the global market is segregated into magnetic resonance-guided breast biopsy, ultrasound-guided breast biopsy, mammography-guided stereotactic breast biopsy, and others, which include thermography and PET. Based on product, the market is categorized into biopsy tables, biopsy needles, localization wires, guidance systems and others, which include punches, markers and sutures. Diversification on the basis of the region is seen into North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa.
Global Breast Biopsy Market: Growth Factors
The global breast biopsy market is a growing market owing to factors such as higher incidence of breast cancer among post-menopausal women, increasing level of awareness, rising geriatric women’s population and developments made in technology. In addition, regions showing a higher female population would be a potential market for breast cancer diagnosis. The requirement for technologically advanced machinery and highly qualified surgeons, doctors and other medical team adds up to the high cost of biopsy surgery, which acts as a restrain to the market growth. Additionally, other factors include substandard healthcare facilities and limited awareness among female population especially in developing regions are the factors that are impacting the market.
Global Breast Biopsy Market: Regional Analysis
The largest share in the breast biopsy market is held by North America. Major factors contributing to the growth in this region are growing awareness for breast cancer, a presence of highly advanced and equipped instruments and increasing supportive governmental initiatives. Countries such the U.S. and Canada are providing a large share in this region. Following the growth in North America region is Europe. Growth in this region can be attributed to the presence of large female population. Italy, Belgium, Germany, the U.K., France, Russia, Spain and Poland are the major countries contributing to the breast biopsy market in the European region. In addition, a fair share is put in by the Asia-Pacific region, which includes countries such as China, India, Japan, Australia and New Zealand. This growth can be attributed to the rising awareness about breast cancer among women and access to optimal treatment facilities. Latin American countries such as Mexico and Brazil and the Middle East and African region such as South Africa are also providing a decent share in the global market growth.
Global Breast Biopsy Market: Competitive Players
Some of the major players in the global breast biopsy market are Cardinal Health Inc., Angiotech, Galini SRL, Carefusion Corp., Cook Medical Incorporated, Ethicon Endo-Surgery, Dickinson and Company, Argon Medical Devices Becto, Hologic Inc., UK Biopsy, Biomed Diagnostics Inc., DTR Medical, F. Hoffmann-La Roche Ltd., Bard Peripheral Vascular Inc., Mammotome, Intact Medical, Laboratory Corporation of America Holdings and OncoCyte Corporation.
Global Breast Biopsy Market: Regional Segment Analysis
What Reports Provides
Request the coronavirus impact analysis across industries and markets